chr16-8848000-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000565221.5(PMM2):​n.*534G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.269 in 614,406 control chromosomes in the GnomAD database, including 22,908 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5473 hom., cov: 32)
Exomes 𝑓: 0.27 ( 17435 hom. )

Consequence

PMM2
ENST00000565221.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.685

Publications

8 publications found
Variant links:
Genes affected
PMM2 (HGNC:9115): (phosphomannomutase 2) The protein encoded by this gene catalyzes the isomerization of mannose 6-phosphate to mannose 1-phosphate, which is a precursor to GDP-mannose necessary for the synthesis of dolichol-P-oligosaccharides. Mutations in this gene have been shown to cause defects in glycoprotein biosynthesis, which manifests as carbohydrate-deficient glycoprotein syndrome type I. [provided by RefSeq, Jul 2008]
PMM2 Gene-Disease associations (from GenCC):
  • congenital disorder of glycosylation type I
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • PMM2-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-8848000-G-A is Benign according to our data. Variant chr16-8848000-G-A is described in ClinVar as Benign. ClinVar VariationId is 321231.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.324 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PMM2NM_000303.3 linkc.*175G>A 3_prime_UTR_variant Exon 8 of 8 ENST00000268261.9 NP_000294.1 O15305-1A0A0S2Z4J6Q59F02
PMM2XM_047434215.1 linkc.*175G>A 3_prime_UTR_variant Exon 6 of 6 XP_047290171.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PMM2ENST00000268261.9 linkc.*175G>A 3_prime_UTR_variant Exon 8 of 8 1 NM_000303.3 ENSP00000268261.4 O15305-1

Frequencies

GnomAD3 genomes
AF:
0.265
AC:
40239
AN:
151944
Hom.:
5469
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.241
Gnomad AMR
AF:
0.218
Gnomad ASJ
AF:
0.222
Gnomad EAS
AF:
0.320
Gnomad SAS
AF:
0.338
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.265
Gnomad OTH
AF:
0.248
GnomAD4 exome
AF:
0.270
AC:
124833
AN:
462346
Hom.:
17435
Cov.:
4
AF XY:
0.274
AC XY:
67065
AN XY:
244962
show subpopulations
African (AFR)
AF:
0.266
AC:
3538
AN:
13318
American (AMR)
AF:
0.184
AC:
4448
AN:
24180
Ashkenazi Jewish (ASJ)
AF:
0.216
AC:
3137
AN:
14510
East Asian (EAS)
AF:
0.310
AC:
9518
AN:
30710
South Asian (SAS)
AF:
0.333
AC:
16260
AN:
48870
European-Finnish (FIN)
AF:
0.284
AC:
8289
AN:
29218
Middle Eastern (MID)
AF:
0.231
AC:
468
AN:
2026
European-Non Finnish (NFE)
AF:
0.264
AC:
72227
AN:
273082
Other (OTH)
AF:
0.263
AC:
6948
AN:
26432
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4692
9384
14077
18769
23461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.265
AC:
40263
AN:
152060
Hom.:
5473
Cov.:
32
AF XY:
0.268
AC XY:
19891
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.264
AC:
10927
AN:
41464
American (AMR)
AF:
0.217
AC:
3323
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.222
AC:
770
AN:
3468
East Asian (EAS)
AF:
0.320
AC:
1653
AN:
5172
South Asian (SAS)
AF:
0.338
AC:
1627
AN:
4814
European-Finnish (FIN)
AF:
0.298
AC:
3145
AN:
10566
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.265
AC:
18016
AN:
67974
Other (OTH)
AF:
0.250
AC:
528
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1484
2969
4453
5938
7422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.255
Hom.:
6555
Bravo
AF:
0.254
Asia WGS
AF:
0.332
AC:
1155
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

PMM2-congenital disorder of glycosylation Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.3
DANN
Benign
0.68
PhyloP100
-0.69
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072688; hg19: chr16-8941857; API